|
gptkb:rifampin
|
gptkb:liver_disease
|
|
gptkb:Rybix_ODT
|
concurrent use of MAO inhibitors
|
|
gptkb:Septra
|
severe liver disease
|
|
gptkb:OGTT
|
known diabetes mellitus
|
|
gptkb:DB08890
|
active pathological bleeding
|
|
gptkb:CPAP
|
gptkb:pneumonia
|
|
gptkb:actinomycin_D
|
pregnancy
|
|
gptkb:Trimetazidine
|
gptkb:Parkinson's_disease
|
|
gptkb:Estrofem
|
active thromboembolic disorders
|
|
gptkb:Vemlidy
|
hypersensitivity to tenofovir alafenamide
|
|
gptkb:Eszopiclone
|
severe liver impairment
|
|
gptkb:benazepril
|
history of angioedema
|
|
gptkb:Electroshock_Therapy
|
unstable cardiovascular conditions
|
|
gptkb:ONZETRA_Xsail
|
peripheral vascular disease
|
|
gptkb:C11216
|
patients with peptic ulcer
|
|
gptkb:nilotinib
|
hypomagnesemia
|
|
gptkb:Pyrimethamine
|
Megaloblastic anemia
|
|
gptkb:Diclofenac
|
third trimester of pregnancy
|
|
gptkb:sennosides
|
intestinal obstruction
|
|
gptkb:amitriptyline
|
severe liver disease
|